Can you be protected against COVID-19 without antibodies?
In just a few months, the coronavirus has gone from being completely unknown to being the focus of countless scientific investigations around the world....
Service News from Inmunología
Immuneel Therapeutics, Hospital Clínic de Barcelona & IDIBAPS Announce a Strategic collaboration & a License Agreement
Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Hospital...
A consortium of European hospitals led by Clínic IDIBAPS is launching a cellular immunotherapy project to tackle COVID-19 with the support of Cellnex Telecom
Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better understanding...
A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures
Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating hematological...
Evolution of cancer immunotherapy: from bone marrow transplant to CAR
The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining the...